| Financial Year |
March 31 2023 |
| Monetary Funds |
240,182,247.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
62,058,556.24 |
| Accounts Receivable |
456,712,782.12 |
| Advances to Suppliers |
21,642,345.70 |
| Other Receivables |
17,746,533.53 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
430,878,356.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,428,170.01 |
| Total Current Assets |
1,311,051,591.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,146,942.13 |
| Investment Properties |
-- |
| Fixed Assetes |
10,199,753.20 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,397,913.07 |
| R&D expenses |
1,967,225.15 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,223,164.93 |
| Deferred Income Tax Assets |
4,999,024.21 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
239,513,373.70 |
| Total Assets |
1,550,564,965.56 |
| Short-Term Loans |
177,481,789.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,900,000.00 |
| Accounts Payable |
230,903,034.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,028,710.50 |
| Taxes Payable |
5,300,382.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,384,159.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,902,085.97 |
| Other Current Liabilities |
390,166.61 |
| Sub-Total of Current Liabilities |
513,017,591.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
16,002,598.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,765,610.05 |
| Total Liabilities |
529,783,202.02 |
| Paid-In Capital(Or Share Stock) |
504,751,147.00 |
| Capital Surplus |
236,665,406.39 |
| Surplus Reserve |
32,743,801.66 |
| LESS:Treasury Stock |
21,539,108.00 |
| Undistributed Profits |
250,481,605.84 |
| Minority Stockholder's Interest |
3,732,672.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,017,049,090.55 |
| Owner's Equity（Stockholder's Equity） |
1,020,781,763.54 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,550,564,965.56 |
